Screener
Climb Bio, Inc. CLYM Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Long-term marketable securities | 36,741 | 59,572 |
| Operating lease right-of-use assets | 447 | 505 |
| Property and equipment, net | 250 | 288 |
| Other long-term assets | 1,530 | 1,530 |
| Total assets | $152,372 | $167,744 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $860 | $2,269 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Climb Bio, Inc.'s deferred tax assets and other non-current assets?
- Climb Bio, Inc. (CLYM) reported deferred tax assets and other non-current assets of $1.53M in Q1 2026.
- How has Climb Bio, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Climb Bio, Inc.'s deferred tax assets and other non-current assets increased by 577.0% year-over-year, from $226K to $1.53M.
- What is the long-term trend for Climb Bio, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Climb Bio, Inc.'s deferred tax assets and other non-current assets has grown at a -10.3% compound annual growth rate (CAGR), from $2.63M to $1.53M.
Ask your AI about Climb Bio, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude